pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
JOURNEY · news · pharmadog
← back to JOURNEY
News mentioning JOURNEY
31
stories
14h
Opinion: How Josée became one of the 7.9% of Québécois who die by assisted suicide
stat
1d
BlossomHill eyes $112M IPO harvest to bankroll potential Tagrisso challenger
fiercebiotech
5d
Daiichi’s pipeline falls behind rivals as cash flow nears peak: analysts
biospace
6d
Vertex’s latest autoimmune TCE play involves $28M upfront to AbCellera
fiercebiotech
7d
Eli Lilly tops new biopharma ranking on launch success, development speed
fiercebiotech
8d
STAT+: Pharmalittle: We’re reading about a U.S. peptide panel’s votes, Amgen scuffling with the FDA, and more
stat
8d
[Podcast] From Protocol to Patient: Inside Clinical Supply with Almac Clinical Services
biopharma dive
8d
FDA has recommitted to adcomms—but to what end?
biospace
11d
Scribe secures $129M in a rare gene editing IPO
biopharma dive
12d
STAT+: Pharmalittle: We’re reading about Lilly obesity drug data, a push for FDA to ban DTC ads, and more
stat
13d
From Big Pharma to specialty: why moving closer to the patient changes everything
biospace
15d
‘There is always a first’: Why US biotech Axiom will begin its IPO journey in Hong Kong
fiercebiotech
15d
Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence
biospace
Jun 30, 26
STAT+: All of Us tests a new approach to collect real-world data for research
stat
Jun 25, 26
De-Risking a Rare Disease Launch Starts with Precision
fiercebiotech
Jun 16, 26
FDA staff scrutinizes evidence supporting Moderna’s flu vaccine
biopharma dive
Jun 10, 26
Opinion: ‘They all think I’m insane’: What it’s like to start medical residency at 72
stat
Jun 4, 26
Opinion: Lawmakers promised cancer patients would be protected from Medicaid cuts. Now CMS says otherwise
stat
Jun 3, 26
STAT+: What the pope’s encyclical on AI means for Catholic hospitals, and all of health care
stat
May 29, 26
Replimune takes third swing at cancer drug approval following ‘productive’ FDA talks
biopharma dive
May 18, 26
STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much more
stat
May 12, 26
PCOS’s new name is PMOS, a small letter change that required a big scientific process
stat
May 11, 26
STAT+: Pharmalittle: We’re reading about Medicare and Alzheimer’s drugs, estrogen patch shortages, and more
stat
May 11, 26
Precision in motion: Decoding the critical operations behind the logistics of next-generation cell and gene therapies
biopharma dive
May 8, 26
Opinion: We need more men in nursing
stat
May 7, 26
Key takeaways from WHO briefing on hantavirus cruise ship outbreak
stat
May 7, 26
Angelini to buy Catalyst in $4B play for rare neuro drugs
biopharma dive
May 5, 26
Coordinating Care in Multiple Myeloma Across Practice Settings
onclive
Apr 29, 26
Food safety experts warn of USDA brain drain
stat
Apr 28, 26
Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.
biopharma dive
← prev
page 1 of 2
next →
